We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

AI-Driven Chest X-Ray Solution Offers Enhanced Lung Nodule Detection

By MedImaging International staff writers
Posted on 16 Jan 2024
Print article
Image: The qXR-LN uses AI to identify and localize lung nodules (Photo courtesy of Qure.ai)
Image: The qXR-LN uses AI to identify and localize lung nodules (Photo courtesy of Qure.ai)

Chest X-rays (CXRs) are a fundamental diagnostic tool, accounting for about 25% of all diagnostic imaging procedures annually. Their widespread use in diagnosing various cardiothoracic conditions is due to their accessibility, mobility, cost-effectiveness, and familiarity compared to other imaging modalities. However, CXRs are prone to misinterpretation, with error rates up to 30%. Previous studies have highlighted this issue, showing inter-radiologist and physician agreement rates as low as 78%. Misinterpretations can have serious implications, as revealed by studies where 19% of lung tumors, appearing as pulmonary nodules on CXRs, were initially missed, potentially leading to fatal outcomes for patients. Now, a novel CXR-based solution uses artificial intelligence (AI) to identify and localize potentially malignant pulmonary nodules, thereby significantly aiding the fight against lung cancer.

qXR for Lung Nodule (qXR – LN) from Qure.ai (Mumbai, India) represents a breakthrough in computer-aided detection software. It is designed to identify and highlight suspected pulmonary nodules ranging from 6 to 30 mm, specifically targeting the incidental adult population. This tool, a game-changer in diagnostic technology, can also function as a crucial second reader in reviewing adult frontal (AP/PA) chest radiographs taken on digital radiographic systems. Qure.ai has validated the safety and efficacy of its lung nodule device through two pivotal studies. The first study confirmed its standalone effectiveness, achieving a 94% Area Under the Curve (AUC) for nodule detection. The second study demonstrated that, with qXR-LN assistance, some emergency room physicians and pulmonologists nearly matched or even exceeded the baseline performance of radiologists.

The early detection of lung nodules in plain film radiography is crucial for the timely identification of cancer risks, allowing for prompt intervention and improved patient outcomes. Accurate nodule detection is essential for treatment planning, disease progression monitoring, and reducing false positives and negatives, thereby enhancing healthcare efficiency. Innovations like qXR-LN are pivotal in evolving pulmonary imaging, especially in the field of oncology. The criticality of early-stage lung cancer detection underscores the importance of tools like qXR-LN in identifying incidental nodules at an early stage. With its recent FDA clearance, qXR-LN stands as the only FDA-cleared solution for detecting and localizing lung nodules using computer vision, targeting radiologists, pulmonologists, and emergency room physicians as its primary users.

“With this latest addition to our large series of recent FDA clearances, we are steadfast in our unwavering commitment to the US healthcare space,” said Prashant Warier, Co-Founder and CEO of Qure.ai. “Having already effectively deployed and implemented this solution globally, this clearance marks yet another ground-breaking leap in our pioneering efforts to combat lung cancer. Our heightened emphasis on the North American marketplace solidifies our commitment to making a meaningful impact in the fight against this deadly disease and underscores our dedication to advancing healthcare through innovation, providing a transformative solution enhancing the early detection of cancer and ultimately improving patient outcomes.”

Gold Member
Solid State Kv/Dose Multi-Sensor
Radiology System
Riviera SPV AT
MRI System
uMR 588
Oncology Information System

Print article



view channel
Image: The VR visualization platform provides patients and surgeons with access to real-time 3D medical imaging (Photo courtesy of Avatar Medical)

VR Visualization Platform Creates 3D Patient Avatars from CT and MR Images in Real-Time

Surgeons and patients must currently rely on black and white medical images interpreted by radiologists. This limitation becomes more pronounced in complex surgeries, leading to issues such as patient... Read more


view channel
Image: Intravascular ultrasound provides a more accurate and specific picture of the coronary arteries (Photo courtesy of 123RF)

Intravascular Imaging Significantly Improves Outcomes in Cardiovascular Stenting Procedures

Individuals with coronary artery disease, which involves plaque accumulation in the arteries leading to symptoms like chest pain, shortness of breath, and heart attacks, often undergo a non-surgical procedure... Read more

Nuclear Medicine

view channel
Image: The PET imaging technique can noninvasively detect active inflammation before clinical symptoms arise (Photo courtesy of 123RF)

New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear

Rheumatoid arthritis, the most common form of inflammatory arthritis, affects 18 million people globally. It is a complex autoimmune disease marked by chronic inflammation, leading to cartilage and bone... Read more

General/Advanced Imaging

view channel
Image: Routine chest CT holds untapped potential for revealing patients at risk for cardiovascular disease (Photo courtesy of Johns Hopkins)

Routine Chest CT Exams Can Identify Patients at Risk for Cardiovascular Disease

Coronary artery disease (CAD) is the primary cause of death globally. Adults without symptoms but at risk can be screened using EKG-gated coronary artery calcium (CAC) CT scans, which are crucial in assessing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.